Tacroz/Tacroz Forte

Tacroz/Tacroz Forte Indications/Uses

tacrolimus

Manufacturer:

Glenmark

Distributor:

SB Pharma
Full Prescribing Info
Indications/Uses
Tacroz: Tacrolimus Ointment 0.03% w/w is indicated in adults, adolescents and children from the age of 2 years.
Atopic Dermatitis flare treatment: Adults and adolescents (16 years of age and above): Treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.
Children (2 years of age and above): Treatment of moderate to severe atopic dermatitis in children who failed to respond adequately to conventional therapies such as topical corticosteroids.
Maintenance treatment: Treatment of moderate to severe atopic dermatitis for the prevention of atopic dermatitis flares and the prolongation of atopic dermatitis flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).
Tacroz Forte: Tacrolimus Ointment 0.1% w/w is indicated in adults and adolescents (16 years of age and above).
Atopic Dermatitis flare treatment: Adults and adolescents (16 years of age and above): Treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.
Maintenance treatment: Treatment of moderate to severe atopic dermatitis for the prevention of atopic dermatitis flares and the prolongation of atopic dermatitis flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in